178 related articles for article (PubMed ID: 19341914)
1. Nanobiotechnology for hemoglobin-based blood substitutes.
Chang TM
Crit Care Clin; 2009 Apr; 25(2):373-82, Table of Contents. PubMed ID: 19341914
[TBL] [Abstract][Full Text] [Related]
2. Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.
Chang TM
Biochim Biophys Acta; 2008 Oct; 1784(10):1435-40. PubMed ID: 18565337
[TBL] [Abstract][Full Text] [Related]
3. Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules.
Chang TM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):418-30. PubMed ID: 20564467
[TBL] [Abstract][Full Text] [Related]
4. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
[TBL] [Abstract][Full Text] [Related]
5. S-nitrosylated polyethylene glycol-conjugated hemoglobin derivative as a candidate material for oxygen therapeutics.
Nakai K; Sakuma I; Togashi H; Yoshioka M; Sugawara T; Satoh H; Kitabatake A
Adv Exp Med Biol; 2003; 519():207-16. PubMed ID: 12675217
[No Abstract] [Full Text] [Related]
6. Blood substitutes: possibilities with nanotechnology.
Alam F; Yadav N; Ahmad M; Shadan M
Indian J Hematol Blood Transfus; 2014 Sep; 30(3):155-62. PubMed ID: 25114400
[TBL] [Abstract][Full Text] [Related]
7. Lowering of elevated tissue PCO2 in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxidant properties.
Bian Y; Wei G; Chang TM
Artif Cells Nanomed Biotechnol; 2013 Feb; 41(1):60-8. PubMed ID: 23347056
[TBL] [Abstract][Full Text] [Related]
8. Polyhemoglobin-fibrinogen: a novel oxygen carrier with platelet-like properties in a hemodiluted setting.
Wong NS; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(5):481-9. PubMed ID: 17922313
[TBL] [Abstract][Full Text] [Related]
9. Extraction of superoxide dismutase, catalase, and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase.
Guo C; Gynn M; Chang TM
Artif Cells Nanomed Biotechnol; 2015 Jun; 43(3):157-62. PubMed ID: 25961364
[TBL] [Abstract][Full Text] [Related]
10. Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation.
Chang TM; D'Agnillo F; Yu WP; Razack S
Adv Drug Deliv Rev; 2000 Feb; 40(3):213-8. PubMed ID: 10837791
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin-based red blood cell substitutes.
Chang TM
Artif Organs; 2004 Sep; 28(9):789-94. PubMed ID: 15320941
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects on the histology and function of livers and spleens in rats after 33% toploading of PEG-PLA-nano artificial red blood cells.
Liu ZC; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(6):513-24. PubMed ID: 19043818
[TBL] [Abstract][Full Text] [Related]
13. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond.
Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2012 Jun; 40(3):197-9. PubMed ID: 22409281
[TBL] [Abstract][Full Text] [Related]
14. Are newer generation hemoglobin-based oxygen carriers safe: do they offer an answer?
Jahr JS
Vascul Pharmacol; 2010; 52(5-6):214. PubMed ID: 20060496
[No Abstract] [Full Text] [Related]
15. [Effectiveness of oxygen delivery to tissues during complete replacement of blood by bovine polyhemoglobin].
Iarochkin VS; Suvorov AV; Tarasenko IS; Kruglova TA; Rozenberg GIa
Gematol Transfuziol; 1993 Jun; 38(6):15-8. PubMed ID: 8307267
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin-based oxygen carriers: disclosed history and the way ahead: the relativity of safety.
Weiskopf RB
Anesth Analg; 2014 Oct; 119(4):758-760. PubMed ID: 25232689
[No Abstract] [Full Text] [Related]
17. Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase.
Gu J; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(2):69-77. PubMed ID: 19229698
[TBL] [Abstract][Full Text] [Related]
18. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
Bian Y; Rong Z; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2011 Jun; 39(3):127-36. PubMed ID: 21574914
[TBL] [Abstract][Full Text] [Related]
19. Reconstructing hemoglobin-based oxygen carriers.
Greenburg AG; Light WR; Dubé GP
Transfusion; 2010 Dec; 50(12):2764-7; author reply 2767. PubMed ID: 21126254
[No Abstract] [Full Text] [Related]
20. The immunological properties of stroma-free polyhemolysate containing catalase and superoxide dismutase activities prepared by polymerized bovine stroma-free hemolysate.
Zhu H; Du Q; Chen C; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2010 Apr; 38(2):57-63. PubMed ID: 20205612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
